Brief: Oncternal Therapeutics Inc Posts Q4 Loss Per Share $0.09
11/03/2021 22:59
March 11 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS PROVIDES BUSINESS UPDATE AND
ANNOUNCES
FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.09
* GRANT REVENUE WAS $1.6 MILLION FOR Q4 ENDED DECEMBER 31,
2020
Source text for Eikon: ID:nGNX9TTlll
Further company coverage: ONCT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;